Kera Therapeutics
Medfield · Founded 2020
About Kera Therapeutics
Kera Therapeutics focuses on cytoprotective and pro-regenerative technologies for preventing reversing ocular cell death.
Company Facts
- Founded: 2020
- Legal name: Kera Therapeutics Inc.
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Funding stage: Seed
- Last round: Seed (Jun 2022)
Social Profiles
Canonical: https://fsome.com/organization/kera-therapeutics-8363642 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.